1. Home
  2. MGRC vs DYN Comparison

MGRC vs DYN Comparison

Compare MGRC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McGrath RentCorp

MGRC

McGrath RentCorp

SELL

Current Price

$112.98

Market Cap

2.9B

ML Signal

SELL

DYN

Dyne Therapeutics Inc.

SELL

Current Price

$14.23

Market Cap

2.8B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MGRC
DYN
Founded
1979
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
MGRC
DYN
Price
$112.98
$14.23
Analyst Decision
Buy
Strong Buy
Analyst Count
3
17
Target Price
★ $145.40
$35.73
AVG Volume (30 Days)
135.9K
★ 3.0M
Earning Date
10-28-2026
11-04-2026
Dividend Yield
★ 1.75%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.47
N/A
Revenue
★ $944,235,000.00
N/A
Revenue This Year
$2.01
N/A
Revenue Next Year
$4.41
N/A
P/E Ratio
$45.79
★ N/A
Revenue Growth
★ 3.65
N/A
52 Week Low
$94.99
$14.00
52 Week High
$125.83
$27.31

Technical Indicators

Market Signals
Indicator
MGRC
DYN
Relative Strength Index (RSI) 46.95 27.68
Support Level $109.63 N/A
Resistance Level $118.53 $19.46
Average True Range (ATR) 2.56 0.74
MACD -0.19 0.16
Stochastic Oscillator 18.17 4.29

Price Performance

Historical Comparison
MGRC
DYN

About MGRC McGrath RentCorp

McGrath RentCorp is a diversified business-to-business rental company with three rental divisions: relocatable modular buildings, portable storage containers, and electronic test equipment. It comprises four reportable business segments, namely the Modular Building segment (Mobile Modular), which generates maximum revenue; the Portable Storage segment (Portable Storage); the Electronic Test Equipment segment (TRS-RenTelco); and its classroom manufacturing business (Enviroplex), which sells modular buildings used as classrooms in California. The company generates its revenues mainly from the rental of its equipment under operating leases, with sales of equipment occurring in the normal course of business.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: